DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,038 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $317,239,288 | -29.9% | 1,269,719 | -30.0% | 0.36% | -29.8% |
Q1 2024 | $452,740,110 | +10.3% | 1,812,991 | +2.2% | 0.51% | +4.5% |
Q4 2023 | $410,333,533 | -12.4% | 1,773,725 | -6.0% | 0.49% | -18.6% |
Q3 2023 | $468,162,226 | +3.0% | 1,886,990 | -0.4% | 0.60% | +9.2% |
Q2 2023 | $454,479,856 | +136.1% | 1,893,666 | +147.9% | 0.55% | +122.6% |
Q1 2023 | $192,506,641 | -6.9% | 763,794 | -2.0% | 0.25% | -15.1% |
Q4 2022 | $206,772,796 | -5.7% | 779,040 | -8.3% | 0.29% | -7.6% |
Q3 2022 | $219,378,868 | +0.3% | 849,351 | -1.5% | 0.32% | -42.8% |
Q2 2022 | $218,698,000 | -33.6% | 862,645 | -23.2% | 0.55% | -19.2% |
Q1 2022 | $329,326,000 | -13.3% | 1,122,712 | -2.8% | 0.68% | -6.3% |
Q4 2021 | $379,852,000 | +19.7% | 1,154,531 | +10.8% | 0.73% | +14.8% |
Q3 2021 | $317,342,000 | +10.3% | 1,042,380 | -2.8% | 0.64% | +14.0% |
Q2 2021 | $287,793,000 | -13.7% | 1,072,414 | -27.6% | 0.56% | -17.1% |
Q1 2021 | $333,340,000 | -1.9% | 1,480,986 | -3.2% | 0.67% | -2.5% |
Q4 2020 | $339,818,000 | +22.9% | 1,529,743 | +19.1% | 0.69% | +12.4% |
Q3 2020 | $276,608,000 | +418.9% | 1,284,572 | +326.1% | 0.61% | +394.4% |
Q2 2020 | $53,309,000 | +23.7% | 301,465 | -3.2% | 0.12% | +6.9% |
Q1 2020 | $43,084,000 | -14.0% | 311,272 | -4.6% | 0.12% | +11.5% |
Q4 2019 | $50,099,000 | +17.1% | 326,427 | +10.2% | 0.10% | +10.6% |
Q3 2019 | $42,800,000 | +1.7% | 296,337 | +0.6% | 0.09% | +4.4% |
Q2 2019 | $42,096,000 | +14.8% | 294,539 | +6.0% | 0.09% | +9.8% |
Q1 2019 | $36,669,000 | +21.5% | 277,754 | -5.1% | 0.08% | +10.8% |
Q4 2018 | $30,170,000 | -8.4% | 292,577 | -3.4% | 0.07% | +8.8% |
Q3 2018 | $32,923,000 | +6.4% | 302,997 | -3.3% | 0.07% | +3.0% |
Q2 2018 | $30,931,000 | +0.9% | 313,445 | +0.2% | 0.07% | +1.5% |
Q1 2018 | $30,643,000 | +0.7% | 312,973 | -4.5% | 0.06% | +3.2% |
Q4 2017 | $30,417,000 | +3.1% | 327,702 | -4.8% | 0.06% | 0.0% |
Q3 2017 | $29,514,000 | +0.3% | 344,077 | -1.4% | 0.06% | -4.5% |
Q2 2017 | $29,438,000 | +0.2% | 348,828 | +1.6% | 0.07% | -1.5% |
Q1 2017 | $29,367,000 | +9.7% | 343,348 | -0.1% | 0.07% | +4.7% |
Q4 2016 | $26,759,000 | +1.2% | 343,763 | +1.9% | 0.06% | +28.0% |
Q3 2016 | $26,449,000 | -90.0% | 337,403 | -87.2% | 0.05% | -92.3% |
Q2 2016 | $265,745,000 | +1.0% | 2,631,139 | -5.1% | 0.65% | +0.2% |
Q1 2016 | $263,118,000 | +4.3% | 2,773,750 | +2.2% | 0.65% | +6.0% |
Q4 2015 | $252,185,000 | +5.8% | 2,715,175 | -2.9% | 0.62% | +2.7% |
Q3 2015 | $238,349,000 | +27.3% | 2,797,197 | +27.9% | 0.60% | +39.6% |
Q2 2015 | $187,184,000 | -3.8% | 2,186,990 | -4.5% | 0.43% | -0.7% |
Q1 2015 | $194,478,000 | +4.1% | 2,290,676 | +5.1% | 0.43% | +4.3% |
Q4 2014 | $186,794,000 | -9.3% | 2,179,371 | -19.6% | 0.41% | -11.3% |
Q3 2014 | $205,976,000 | +1.9% | 2,710,913 | +5.6% | 0.47% | +0.9% |
Q2 2014 | $202,040,000 | -3.7% | 2,566,252 | -8.2% | 0.46% | -4.3% |
Q1 2014 | $209,706,000 | -4.1% | 2,796,079 | -1.3% | 0.48% | -4.3% |
Q4 2013 | $218,669,000 | +18.4% | 2,832,485 | +6.4% | 0.51% | +9.8% |
Q3 2013 | $184,616,000 | +26.3% | 2,663,240 | +15.3% | 0.46% | +14.1% |
Q2 2013 | $146,176,000 | – | 2,309,265 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |